Skip to main content
. 2022 Nov 18;18(6):1179–1185. doi: 10.4103/1673-5374.360164

Figure 2.

Figure 2

A theoretical framework outlining the neuroprotective mechanisms of trehalose as a DMT for neurodegenerative diseases, based on the framework by Cumming (2017).

APP: Amyloid precursor protein; DMT: disease-modifying treatment; NDD: neurodegenerative diseases.